Evidence map›Paper›PMID 30420626›Full record

ArticleNature immunology2018

The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness.

Daisy Melandri, Iva Zlatareva, Raphaël A G Chaleil, Robin J Dart, Andrew Chancellor, Oliver Nussbaumer, Oxana Polyakova, Natalie A Roberts, Daniela Wesch, Dieter Kabelitz and 6 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 229 citations in OpenAlex.

  1. γδ T cells in colorectal and liver cancer.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. International journal of molecular sciences · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Daisy MelandriPeter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK.
Iva ZlatarevaPeter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK.
Raphaël A G ChaleilBiomolecular Modelling Laboratory, The Francis Crick Institute, London, UK.
Robin J DartPeter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0003-3470-8210
Andrew ChancellorAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Oliver NussbaumerGammaDelta Therapeutics, London BioScience Innovation Center, London, UK.
Oxana PolyakovaGammaDelta Therapeutics, London BioScience Innovation Center, London, UK.
Natalie A RobertsPeter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK.
Daniela WeschInstitute of Immunology, University Hospital Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany.
Dieter KabelitzInstitute of Immunology, University Hospital Schleswig-Holstein, Christian-Albrechts University, Kiel, Germany.
Peter M IrvingDepartment of Gastroenterology, Guy's and St Thomas' Foundation Trust, London, UK.
Susan JohnPeter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-5620-1982
Salah MansourAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Paul A BatesBiomolecular Modelling Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-0621-0925
Pierre VantouroutPeter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK. pierre.vantourout@kcl.ac.uk.ORCID http://orcid.org/0000-0001-7287-5517
Adrian C HaydayPeter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK. adrian.hayday@kcl.ac.uk.ORCID http://orcid.org/0000-0002-9495-5793
King's College London · GBThe Francis Crick Institute · GBChristian-Albrechts-Universität zu Kiel · DEUniversity of Southampton · GBGuy's and St Thomas' NHS Foundation Trust · GB

Funding

Cancer Research UK 10748Cancer Research UK 23562Medical Research Council MR/P021964/1Wellcome Trust FC001003
6 · The paper itself

Abstract

T lymphocytes expressing γδ T cell antigen receptors (TCRs) comprise evolutionarily conserved cells with paradoxical features. On the one hand, clonally expanded γδ T cells with unique specificities typify adaptive immunity. Conversely, large compartments of γδTCR

Indexed as

Adaptive ImmunityAnimalsAntigensButyrophilinsHumansImmunity, InnateLymphocyte ActivationMiceMice, Inbred C57BLReceptors, Antigen, T-Cell, gamma-deltaAntigensButyrophilinsReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID30420626
PMCPMC6874498
OpenAlexW2899542051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.